LEP and sleep apnea syndrome: We have used our diet-induced obesity (DIO) mouse model of SDB and have shown that intranasal (IN) leptin treats OIRD in DIO male mice, decreasing the number of apneas and increasing minute ventilation without decreasing analgesia (Freire et al., 2020).